The relationship between subcortical tau pathology and Alzheimer's disease.
about
Calcium-Sensing Receptors of Human Neural Cells Play Crucial Roles in Alzheimer's Disease"Is dopamine involved in Alzheimer's disease?"Turning on the Light Within: Subcortical Nuclei of the Isodentritic Core and their Role in Alzheimer's Disease PathogenesisThe preclinical phase of the pathological process underlying sporadic Alzheimer's diseaseBeneficial Effects of Sulforaphane Treatment in Alzheimer's Disease May Be Mediated through Reduced HDAC1/3 and Increased P75NTR ExpressionNoradrenergic regulation of glial activation: molecular mechanisms and therapeutic implications.Calcium-Sensing Receptors of Human Astrocyte-Neuron Teams: Amyloid-β-Driven Mediators and Therapeutic Targets of Alzheimer's DiseasePrimary age-related tauopathy (PART): a common pathology associated with human agingEarly neurone loss in Alzheimer's disease: cortical or subcortical?Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease.Extracellular Vesicles Isolated from the Brains of rTg4510 Mice Seed Tau Protein Aggregation in a Threshold-dependent Manner.A rapid gene delivery-based mouse model for early-stage Alzheimer disease-type tauopathyCauses, consequences, and cures for neuroinflammation mediated via the locus coeruleus: noradrenergic signaling system.Amyloid β-Exposed Human Astrocytes Overproduce Phospho-Tau and Overrelease It within Exosomes, Effects Suppressed by Calcilytic NPS 2143-Further Implications for Alzheimer's TherapyI2020T mutant LRRK2 iPSC-derived neurons in the Sagamihara family exhibit increased Tau phosphorylation through the AKT/GSK-3β signaling pathway.Dysfunctional Sensory Modalities, Locus Coeruleus, and Basal Forebrain: Early Determinants that Promote Neuropathogenesis of Cognitive and Memory Decline and Alzheimer's Disease.Quantifying the accretion of hyperphosphorylated tau in the locus coeruleus and dorsal raphe nucleus: the pathological building blocks of early Alzheimer's disease.First-in-man tau vaccine targeting structural determinants essential for pathological tau-tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer's disease model.Do astrocytes collaborate with neurons in spreading the "infectious" aβ and Tau drivers of Alzheimer's disease?Down but Not Out: The Consequences of Pretangle Tau in the Locus Coeruleus.Amyloid and tau: neither chicken nor egg but two partners in crime!MicroRNA Expression in the Locus Coeruleus, Entorhinal Cortex, and Hippocampus at Early and Middle Stages of Braak Neurofibrillary Tangle Pathology.Locus coeruleus at asymptomatic early and middle Braak stages of neurofibrillary tangle pathology.Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes.Critical role of somatostatin receptor 2 in the vulnerability of the central noradrenergic system: new aspects on Alzheimer's disease.Vagus somatosensory evoked potentials are delayed in Alzheimer's disease, but not in major depression.Exosomes taken up by neurons hijack the endosomal pathway to spread to interconnected neurons.A method for inferring regional origins of neurodegeneration.Altered Regulation of KIAA0566, and Katanin Signaling Expression in the Locus Coeruleus With Neurofibrillary Tangle Pathology.
P2860
Q26747527-3E3CC616-A1EC-43B7-8C27-42CC07E62A38Q26851680-F8F89496-2D8D-4EED-82E1-20DE0D307F2BQ27027221-750E39B9-E00A-47F6-91E2-1144D8600EE5Q28083428-E8C7B06E-56F8-4181-9DFB-7C0E58C66C2BQ33619463-4B2ACC22-E774-4B0D-85BE-82C928327FCCQ34391616-E7F80508-7872-4BEB-9CF8-904A80FB0ACDQ34391624-1FE4DFE5-9679-4E11-9ADD-755ADBBF592EQ34445021-2DE7BE90-DBC0-48E2-862E-219FB1FC2AEFQ35176873-9AB62FA1-0FBB-4812-A044-A437A14805C1Q36998284-5B5193F6-91F7-4259-BF54-1056C49D92D3Q37066447-9AB4D4BF-2986-4CAA-B36E-2483DF64A46FQ37273007-9D583774-0149-41D4-8061-092402A8E9B1Q38770352-C723302E-134A-4EB5-A12A-E0D56B0B06CFQ38803172-8F1DA5EE-BA28-42D9-B4B7-C07D10A98DA4Q38865951-76788C0C-535F-438E-A255-B096284F4A59Q38875190-03FD8D31-4321-4D84-8CE1-D3032EF4A729Q39002052-EC1D36C0-56C3-4AD8-B685-2432A590D8E7Q39083050-3C7BAE93-1628-46FE-87E3-11B37CF23FDAQ42218999-306AE4F2-B57C-4A20-9CCA-980EF0A0D9E5Q42361161-20BD9916-E2F3-4A60-BEAD-621966D10624Q44934916-302378AF-2C93-4DDC-B854-BA7B3E23B554Q47778002-A564B34C-BD5A-4CFD-BF72-5CEEF0025FB5Q47986956-15530E89-199B-4AF1-953A-A883870FA32FQ48287129-51132629-F341-4528-95ED-C9EE4CB63495Q48332119-2E5AE1FF-58BE-4B59-A671-AB4574A4CD04Q48465888-810E36C0-7039-4359-BEC4-1F932034282EQ49962856-7D369DA0-DE61-4692-BB93-AA949E239210Q50161290-374D5893-2C7D-465D-8DE6-A503111828CBQ55172664-7D1E5B63-9967-4C02-9766-51C1AA636091
P2860
The relationship between subcortical tau pathology and Alzheimer's disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The relationship between subcortical tau pathology and Alzheimer's disease.
@en
type
label
The relationship between subcortical tau pathology and Alzheimer's disease.
@en
prefLabel
The relationship between subcortical tau pathology and Alzheimer's disease.
@en
P2860
P356
P1476
The relationship between subcortical tau pathology and Alzheimer's disease
@en
P2093
Kurt A Jellinger
P2860
P304
P356
10.1042/BST20120034
P577
2012-08-01T00:00:00Z